Submitted:
29 July 2026
Posted:
30 July 2026
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Key Changes from the Previous Approach
3. Strategy for Writing the Final Report in IMRD Format
4. Rationale for a Systematic Review
5. Literature Searching in Two Phases: Preliminary Phase and Development Phase
5.1. Preliminary Phase: Design, Pilot Search and Registrable Protocol
| Preliminary phase step | What needs to be done | Product to move to development |
| Delimitation of the problem | Review exploratory literature, identify gaps and structure the question using PICO, PECO, PCC, PIRD or CoCoPop. Define population, intervention/test/exposure, comparator or reference, outcomes, context, and possible designs [21,24]. | Structured initial question, working title, essential concepts, preliminary keywords and justification of scientific interest. |
| Pilot search | Test free terms, synonyms, linguistic variants and controlled vocabularies; select sources and grey literature; check sentinel studies, volume of results and applicability of the criteria. An AI agent can propose these elements using the prompt in Annex 3, Table 16, but terms, syntax, filters, references, and identifiers must be manually validated [19,20,33,34,35]. | Refined question and goals; verified preliminary strategy; adjusted sources and eligibility criteria; sentinel studies identified; and anticipated extraction variables. |
| Registrable protocol | Stabilize question, objectives, criteria, sources, strategies, outcomes, variables, risk of bias and synthesis plan. Date and archive pilot searches and versions of the strategy; if AI was used, retain tool and version, date, prompt, input, output, and human validation [2,4,17,19,20,37]. | Dated and, if applicable, recorded in PROSPERO or another registry; reproducible methodological file; and validated plan to start S0. Any subsequent substantial changes will need to be documented as an amendment. |
5.2. Development Phase: the S0-S3 Sequence
6. S0: Identification
7. S1: Screening
8. S2: Eligibility
9. S3: Final Inclusion
10. Risk of Bias: Tools by Design
11. Certainty of the Evidence: GRADE
12. Qualitative Synthesis and Meta-Analysis
13. PRISMA 2020 & Extensions
14. Document Flow, Reproducibility and Auditing
15. Practical Organization for Researchers
| Documentary block | Minimum content | Methodological utility |
| Search strategies | Search engine or platform, date, complete equation, filters, limits, language, time period, number of results obtained in S0, captures if applicable and exported file. | It allows you to reproduce the search, audit S0, verify the search engines used and obtain the initial counts of the PRISMA diagram. |
| Bibliographic exports | Original files in RIS, BibTeX, CSV, or other formats, with normalized name, download date, source, and preservation without loss of metadata. | It preserves the original bibliographic library, facilitates exchange with managers and spreadsheets, and allows you to re-export records without loss of metadata. |
| Deduplication | Tool used, matching criteria, fields compared, number of duplicates removed, and version of the resulting file. | It documents deleted records before screening and prevents literature purge from being a black box. |
| AI Prompts | Phase S0-S3, agent used, version if applicable, date, objective, full prompt used or adapted from Annex 3, input file, output generated in CSV or other documented format and responsible for validation. | It allows you to reconstruct the instructions given to the agent and verify how deduplications, priorities, inclusions, exclusions, or extractions were proposed. |
| Selection decisions | Decision by record or report: include, perhaps, exclude, high/medium/low priority, reason for exclusion, reviewer and resolution of discrepancies. | It connects S1 and S2 with reviewer traceability and exclusion justification. |
| PRISMA Counts | Records identified, duplicates deleted, records screened, records excluded, texts searched, texts evaluated, exclusions on grounds and studies included. | It feeds the PRISMA 2020 diagram and avoids inconsistencies between search, screening, eligibility and final inclusion. |
| Versioning and auditing | File name, ISO date, version, responsible, changes made, link to CSV/RIS/BibTeX and location of supplementary material. | It facilitates future updating of the revision and allows a third party to rebuild the entire process. |
| Reproducible supplement | Supplementary document with search strategies, search engines, dates, S0 counts, S1-S3 selections, tables of results, data matrices, statement on AI and automation adapted from Annex 2, full prompts used or adapted from Annex 3, and materials not included in the main manuscript. | It should contain everything necessary for other researchers to reproduce the study, verify methodological decisions not detailed in the main text, and reconstruct the use of AI using the archived statement and prompts . |
16. Using RevMan Web, GRADEpro, and Companion Tools
17. Artificial Intelligence and Automation Considerations
18. Discussion
19. Limitations of this Methodological Proposal
20. Conclusions
Author contributions
Funding
Ethical approval
Data Availability Statement
Acknowledgments
Conflicts of Interest
Use of artificial intelligence and automation
Annex 1. Minimum S0-S3 Staged CSV Template
| Stage | Minimum fields |
| S0 | id_s0, source, strategy, search_date, source_format, source_file_RIS_BibTeX_CSV, title, authors, year, DOI, PMID, abstract, keywords, MeSH_DeCS, language, document_type, annotation_tags, AI_prompt_S0, AI_output_S0 |
| S1 | id_s0, id_s1, duplicate, deduplication_method, title_abstract_decision, AI_priority, AI_justification, AI_prompt_S1, reexportable_RIS_BibTeX, reviewer1, reviewer2, conflict, final_decision |
| S2 | id_s1, id_s2, full_text_retrieved, full_text_decision, exclusion_reason, AI_extracted_data, AI_prompt_S2, reexportable_RIS_BibTeX, observations, excluded_citation |
| S3 | id_s2, study_id, RIS_BibTeX_reference, included_narrative, included_meta_analysis, outcome, extracted_data, AI_extracted_data, AI_prompt_S3, risk_of_bias, GRADE_certainty, human_review, reexportable_by_synthesis, table_figure |
Annex 2. Suggested Statement on AI and Automation
Annex 3. Reusable prompts for AI agents in S0-S3
| Stage | Prompt Objective | Copyable prompt |
| PRELIMINARY | ||
| Design, pilot search and registrable protocol | Translate a research question into a preliminary systematic review plan by defining the methodological framework, key concepts, controlled vocabulary, pilot search strategies, eligibility criteria and PRISMA planning before the development phase begins. | Act as a specialist in systematic review methodology and bibliographic searching in the health sciences. I am in the PLANNING PHASE of a systematic review. My research question is: [INSERT QUESTION]. I need you to: (1) formulate the question using the most appropriate framework—PICO, PECO, PCC, PIRD or CoCoPop; (2) identify the population, intervention or exposure, comparator and outcomes; (3) propose free-text terms, synonyms and linguistic variants; (4) suggest MeSH, DeCS, Emtree and other relevant controlled vocabulary terms; (5) design a pilot search strategy for PubMed and provide preliminary adaptations for Europe PMC, Web of Science, Embase, CINAHL, the Cochrane Library, the Virtual Health Library and other relevant databases; (6) propose inclusion and exclusion criteria; (7) identify sentinel studies that the search should retrieve; (8) identify potential methodological limitations; (9) propose data-extraction variables; (10) develop a preliminary PRISMA plan specifying the information that should be recorded throughout the review; and (11) propose a bibliographic export structure in CSV format containing the minimum recommended fields—database, authors, year, title, journal, DOI, PMID, abstract, keywords, language, document type, selection decision and notes—to support the S0–S3 stages. Do not fabricate references, DOIs, PMIDs or registration numbers. Clearly distinguish preliminary planning from the formal conduct of the review. Specify which aspects require human validation before the protocol is drafted and explain how the bibliographic records should subsequently be exported to a CSV file for management and traceability. Generate a CSV file containing your initial selection of sentinel studies and preliminary background sources. |
| DEVELOPMENT | ||
|
S0 Normalization of Records |
Review a CSV/RIS/BibTeX file exported from databases and prepare a homogeneous matrix of work. | Act as a methodological assistant for a systematic review. Analyse the reference file that I provide and normalise the available bibliographic fields. Retain title, authors, year, journal, DOI, PMID, abstract, keywords, MeSH/DeCS terms, source, search date, document type, language and URL if available. Do not delete records at this stage. Return a CSV-exportable table, with one row per record, and add an observations column for fields that are missing, inconsistent or require human review. If the input file is in RIS or BibTeX, retain the identifiers and metadata necessary to re-export selected, excluded or questionable records in RIS or BibTeX without loss of information. Do not infer or generate information that is not present in the metadata. [INCLUSION CRITERIA: specify the criteria applicable to S0, derived from the review question, population, intervention/test/exposure, comparator, outcomes, design, sources and limits defined in the protocol.] [EXCLUSION CRITERIA: specify records clearly irrelevant to the question, excluded document types, excluded languages, dates outside the defined period, inadmissible sources or other limits set in the protocol.] |
|
S0 Duplicate Identification |
Detect exact or probable duplicates prior to screening. | Act as a bibliographic deduplication assistant. Compare records by DOI, PMID, title, authors, year, journal and title similarity. Classify each possible duplicate as exact duplicate, probable duplicate or non-duplicate. Always retain the record with the most complete metadata and preserve the source of all duplicate records. Return a CSV-exportable table with id_s0, duplicate_group, proposed_decision, retained_record, removable_records, matching_criterion and justification. Retain the identifiers and metadata necessary to re-export preserved, removable, selected, excluded or doubtful records in RIS or BibTeX without loss of information. Do not delete records; mark all decisions as proposed and pending human validation. [INCLUSION CRITERIA: retain unique records or duplicate records that provide complementary metadata useful for S0 traceability.] [EXCLUSION CRITERIA: mark as removable duplicate records with exact or probable matches according to DOI, PMID, title, authors, year or journal, without losing the original source or relevant metadata.] |
|
S0 Initial Thematic Exploration |
Identify terms, thematic families, and useful signals for screening. | Act as a bibliographic exploration assistant. From titles, abstracts, keywords and MeSH/DeCS terms, identify common terms, synonyms, linguistic variants, related concepts, populations, interventions, exposures, diagnostic tests, comparators, outcomes, study designs and statistical methods mentioned. Return a CSV-exportable matrix with term or concept, approximate frequency, field where it appears, possible relationship with inclusion criteria and observations for reviewing the search strategy or screening. If the matrix is derived from bibliographic references, retain the identifiers necessary to link each thematic signal to the original records and enable re-export in RIS or BibTeX when necessary. Do not modify the protocol criteria; only suggest useful signals for human review. [INCLUSION CRITERIA: identify thematic signals compatible with the review question and with the preliminary criteria for population, intervention/test/exposure, comparator, outcomes and design.] [EXCLUSION CRITERIA: indicate terms, concepts, document types, languages, populations or thematic areas clearly unrelated to the protocol or expressly excluded.] |
|
S1 Screening by Title and Abstract |
Classify records according to inclusion and exclusion criteria. | Act as the second screening assessor of a systematic review. Use only the available title, abstract, keywords, MeSH/DeCS terms, tags and annotations. Review question: [insert question]. For each record, classify the preliminary decision as include, maybe or exclude. In addition, assign priority for full-text retrieval: high, medium, low or exclude. Justify each decision in one sentence using verifiable metadata. If the information is insufficient, use “maybe” and do not exclude definitively. Return a CSV-exportable table with columns: id_s0, AI_decision, full_text_priority, criterion_applied, justification, missing_data and human_review_required. Retain the identifiers and metadata necessary to re-export included, excluded or doubtful records in RIS or BibTeX without loss of information. [INCLUSION CRITERIA: specify population, intervention/test/exposure, comparator, outcomes, design, setting, period, language and any other criteria applicable to title-and-abstract screening.] [EXCLUSION CRITERIA: specify animal studies, letters, editorials, ineligible reviews, non-relevant population, intervention/test/exposure not relevant, non-relevant outcomes, excluded designs, excluded languages or other protocol criteria.] |
|
S1 Full-text prioritization |
Sort the retrieval of full texts by probability of inclusion. | Act as a full-text retrieval prioritisation assistant. Review the records that have not been excluded after title-and-abstract screening. Classify each record as high, medium or low priority for full-text retrieval. Consider population match, intervention/test/exposure, comparator, outcomes, design, methods, keywords, MeSH/DeCS terms, information cited in the abstract, cohort or registry names and signals of extractable data. Return a CSV-exportable table with columns: id_s1, priority, primary_reason, potentially_extractable_variables_or_data, methodological_uncertainties and recommendation_for_human_reviewer. Retain the identifiers and metadata necessary to re-export prioritised, excluded or doubtful records in RIS or BibTeX without loss of information. [INCLUSION CRITERIA: prioritise records with clear or probable correspondence to the population, intervention/test/exposure, comparator, outcomes and design defined for S1.] [EXCLUSION CRITERIA: assign low priority or exclude records with clear signals of an ineligible population, excluded document type, inadmissible design, no relationship to the question or insufficient information to justify immediate retrieval.] |
|
S1 Traceability Report |
Generate summary for the supplementary file. | Act as a methodological documentation assistant. From the S1 screening file, generate a traceability summary with the number of records assessed, records proposed for inclusion, records classified as maybe, records proposed for exclusion, records by high, medium or low full-text priority, main reasons for exclusion, fields used for the decision, records with insufficient information and recommendations for human review. Return the summary in a format suitable for the supplementary documentation file and include a CSV-exportable matrix with the main counts and categories. If the file contains bibliographic references, retain the identifiers and metadata necessary to re-export included, excluded or doubtful records in RIS or BibTeX without loss of information. Add a final statement that all AI decisions are proposals and must be validated by human reviewers. [INCLUSION CRITERIA: summarise as included or potentially included the records that meet or may meet the S1 criteria based on available information.] [EXCLUSION CRITERIA: summarise records excluded or proposed for exclusion using the primary reason applied, avoiding vague categories and distinguishing title-and-abstract exclusion from full-text exclusion.] |
|
S2 Full-Text Eligibility Assessment |
Apply definitive eligibility criteria on full-text articles. | Act as the second eligibility assessor for a systematic review. Review the full text of the report and explicitly compare the population, intervention/test/exposure, comparator or reference standard, outcomes, design, period, setting, extractable data and possible sample overlap with the protocol. Classify the preliminary decision as include, maybe or exclude. If exclusion is proposed, assign a single main reason and justify it with verifiable information from the text, indicating the section, table, figure, page or supplementary material whenever possible. Do not definitively exclude a report if essential information is missing; in that case, classify it as maybe and mark it for mandatory human review. Return a CSV-exportable table with columns: id_s2, AI_full_text_decision, criterion_applied, primary_exclusion_reason, supporting_excerpt_or_data, location_in_text, missing_data, possible_overlap and human_review_required. Retain the bibliographic identifiers necessary to re-export included, excluded or questionable reports in RIS or BibTeX without loss of metadata. [INCLUSION CRITERIA: specify the definitive eligibility criteria applicable to S2, including population, intervention/test/exposure, comparator or reference standard, outcomes, design, period, setting, data availability and methodological requirements defined in the protocol.] [EXCLUSION CRITERIA: specify the single reason for exclusion to be recorded and justified, such as ineligible population, non-relevant intervention/test/exposure, inadequate comparator or reference standard, non-relevant outcomes, excluded design, absence of extractable data, non-retrievable full text, duplicate population or unresolved overlap.] |
|
S2 Full-Text Exclusions Table |
Standardize reasons for exclusion and prepare the PRISMA annex. | Act as a methodological documentation assistant for S2. From the full-text eligibility file, review all excluded or questionable reports and construct an exclusion table with abbreviated citation, id_s2, exclusion_stage, proposed_final_decision, primary_exclusion_reason, PRISMA_compatible_category, brief_justification, location_of_evidence_in_text and observations_for_human_review. Do not use vague reasons such as “not relevant” when a methodological reason can be specified. If more than one reason applies, record only the main reason and mention secondary reasons in the observations column. Return a CSV-exportable matrix and a summary with the number of full texts assessed, excluded by category, pending and proposed for inclusion. Retain the bibliographic identifiers necessary to re-export included, excluded or questionable reports in RIS or BibTeX without loss of metadata. [INCLUSION CRITERIA: consider eligible the full texts that meet the final S2 criteria and provide sufficient information for the intended qualitative or quantitative synthesis.] [EXCLUSION CRITERIA: record a single main reason per excluded text, justified with an explicit and traceable category: population, intervention/test/exposure, comparator or reference standard, outcomes, design, data, duplication, non-retrievable text or another predefined cause.] |
|
S3 Structured Data Extraction |
Extract variables, outcomes and numerical data for synthesis. | Act as a data extraction assistant for a systematic review. From the full text of the included studies, extract only information present in the article or in its supplementary materials. Record study identification, country, design, period, data source, population, sample size, intervention/test/exposure, comparator or reference standard, outcomes, operational definitions, numerical data, units of measurement, corresponding group or arm, effect measures, confidence intervals, 2×2 tables if applicable, events, denominators, means, standard deviations, losses to follow-up, funding, conflicts of interest and methodological notes. For each item, indicate whether it comes from the main text or the supplement and specify the section, table, figure, page or source material. Always separate original data, transformed or calculated data and the justification for any transformation. Do not compute derived data unless expressly requested, and explain any transformation performed. Return a CSV-exportable table with one row per study and outcome, including columns for original_data, transformed_data, unit_of_measurement, comparator_group, exact_source, location_in_text, methodological_uncertainty and human_review. Retain bibliographic identifiers that allow each study to be linked to its original reference and, where appropriate, re-export included references in RIS or BibTeX without loss of metadata. [INCLUSION CRITERIA: extract data only from studies definitively included in S3 for narrative, quantitative or outcome synthesis, based on predefined variables in the protocol and extraction form.] [EXCLUSION CRITERIA: do not extract data from excluded records, duplicate studies, reports with unresolved overlapping populations, unpredefined outcomes, unverifiable data or inferred information that is not present in the text.] |
|
S3 Preparation of synthesis and meta-analysis |
Identify studies and outcomes suitable for narrative or quantitative synthesis. | Act as a synthesis preparation assistant. Review the S3 matrix and group studies by question, comparison, outcome, design, population, intervention/test/exposure, comparator or reference standard, effect measure and data availability. Indicate for each study whether it can contribute to narrative synthesis, meta-analysis, subgroup analysis, sensitivity analysis or tabular description only. Do not recommend meta-analysis solely because data are available; also assess clinical, methodological and statistical compatibility, consistency of definitions, unit of analysis, direction of effect and risk of overlap. Justify exclusions from quantitative synthesis on the basis of clinical heterogeneity, methodological or statistical incompatibility, absence of comparable data, sample overlap or non-combinable outcomes. Return a CSV-exportable table with columns: study_id, outcome, possible_synthesis_type, effect_measure, available_data, clinical_compatibility, methodological_compatibility, statistical_compatibility, reason_no_meta_analysis and human_review. Retain bibliographic identifiers so that each study can be linked to its reference and so that references included in or excluded from each synthesis can be re-exported in RIS or BibTeX when necessary. [INCLUSION CRITERIA: include in each synthesis definitively included studies that share population, comparison, outcome, design, effect measure and clinical, methodological and statistical conditions sufficiently compatible for the intended synthesis.] [EXCLUSION CRITERIA: exclude from a specific synthesis studies included in the review that do not provide combinable data, present unjustifiable heterogeneity, have incompatible outcomes, unresolved overlapping populations or insufficient information for analysis.] |
|
S3 Statistical calculation and verification of the meta-analysis |
Execute or verify statistical calculations with traceable and reproducible tools. | Act as a statistical verification assistant for a systematic review with meta-analysis. From the validated S3 matrix, identify for each outcome the appropriate effect measure, the type of data required, the intended statistical model and the software or analytical tool used for the calculation, for example Copilot Analyst, R with the meta, metafor, mada, diagmeta or netmeta packages, Stata with meta, metan, metareg, midas or metandi, RevMan Web, JASP, Jamovi, Comprehensive Meta-Analysis, MedCalc or another specialised tool. Verify that the input data are sufficient and consistent: events and denominators, means and standard deviations, 2×2 tables, hazard ratios, odds ratios, risk ratios, mean differences, confidence intervals, standard errors or diagnostic matrices, as appropriate. Do not invent missing data or replace statistical decisions not specified in the protocol. Return a CSV-exportable table with columns: study_id, outcome, data_type, effect_measure, planned_model, software_or_agent, package_or_command, required_input_data, available_data, issues_detected, reproducible_calculation, script_or_output_file, main_result and human_review. Retain bibliographic identifiers to link calculations to original references and to allow re-export in RIS or BibTeX of studies included in each analysis when necessary. If code is generated, separate it from the results and state that it must be run and verified in the corresponding software. [INCLUSION CRITERIA: include in the statistical calculation only S3 studies and outcomes with sufficient, comparable and validated data for the intended quantitative synthesis, with a defined or justified effect measure, model and statistical tool.] [EXCLUSION CRITERIA: exclude from the calculation studies without sufficient numerical data, with non-combinable populations or outcomes, unresolved duplicate or overlapping data, incompatible effect measures, uncorrected errors, lack of correspondence with the protocol or lack of human validation of the S3 matrix.] |
|
S3 Final Traceability Report S0-S3 |
Consolidate counts, decisions, and human validation for supplemental material. | Act as a final traceability assistant for a systematic review. Integrate the S0, S1, S2 and S3 files and generate a methodological summary with PRISMA counts, distinguishing records, reports/full texts, studies and studies included in each synthesis. Report the number of records identified, duplicates removed, records screened, records excluded by title and abstract, reports sought for retrieval, reports not retrieved, full-text reports assessed, full-text exclusions by reason, studies included in narrative synthesis and studies included in each meta-analysis. Return a CSV-exportable matrix with counts, decisions and correspondence between phases, and add a table of prompts used with phase, objective, input file, output generated and human validation. Retain the bibliographic identifiers necessary to re-export included, excluded or doubtful records or studies by phase and by synthesis in RIS or BibTeX without loss of metadata. Identify inconsistencies between phases, residual duplicates, records without a final decision, reports without an exclusion reason, included studies without extracted data or PRISMA counts that do not correspond to the source files. Return the report in a format suitable for supplementary material. [INCLUSION CRITERIA: integrate only validated decisions or pending decisions clearly marked in S0-S3, distinguishing identified records, assessed reports, studies included in the review, studies included in narrative synthesis and studies included in each meta-analysis.] [EXCLUSION CRITERIA: do not mix previously excluded records with included studies, do not count duplicates as independent studies, do not confuse reports with studies, do not assign undocumented exclusion reasons and do not generate PRISMA counts without correspondence to the source files.] |
Annex 4. Recommended web resources for systematic reviews
| Resource | Main function | Web address | Use in S0-S3 |
| PRISMA Statement | PRISMA 2020 reporting guides, extensions, checklists, and flowcharts. | https://www.prisma-statement.org/ | Report planning, S0-S3 counts, PRISMA diagram and verification of the final manuscript. |
| PROSPERO | Prospective registry of systematic review protocols with health outcomes. | https://www.crd.york.ac.uk/prospero/ | Preliminary phase: registration of the protocol before S0, amendments and methodological transparency. |
| Cochrane Handbook | Methodological manual for intervention reviews, with guidance on search, selection, extraction, risk of bias, synthesis, meta-analysis, GRADE and interpretation. | https://www.cochrane.org/authors/handbooks-and-manuals/handbook | Cross-sectional methods from protocol to S3: selection, extraction, risk of bias, synthesis, meta-analysis, and certainty. |
| RevMan Web | Cochrane’s platform for managing reviews, study data, analysis, meta-analysis, figures and reporting. | https://revman.cochrane.org/ | S3, structured extraction, analysis, meta-analysis, figures and report. |
| GRADEpro GDT | Summary of Findings tables, evidence profiles, and certainty assessment with GRADE; integration or transfer of data from RevMan Web where appropriate. | https://www.gradepro.org/ | S3, certainty assessment by outcome, SoF tables, evidence profiles, and conclusions. |
| Risk of Bias Tools | Portal of tools for assessing risk of bias, including RoB 2 and ROBINS-I. | https://www.riskofbias.info/ | S3, assessment of risk of bias by design and outcome. |
| Resource | Main function | Web address | Use in S0-S3 |
| PubMed | Free biomedical base including MEDLINE, life science citations, and full-text links when available. | https://pubmed.ncbi.nlm.nih.gov/ | S0, main biomedical search, MeSH, filters, citation export, and PMID retrieval. |
| MEDLINE / Ovid | Advanced bibliographic search interface in MEDLINE, useful for reproducible strategies and expert searches. | https://www.ovid.com/ | S0, reproducible strategies, advanced operators, search history, and exports. |
| Europe PMC | Biomedical literature, preprints, full texts, and links to data when available. | https://europepmc.org/ | S0, complementary search, full text retrieval, pre-publications, and reference checks. |
| Cochrane Library / CENTRAL | Cochrane reviews, protocols and CENTRAL register of controlled trials. | https://www.cochranelibrary.com/ | S0, search for relevant trials, protocols and previous reviews. |
| VHL/LILACS | Latin American and Caribbean literature. | https://bvsalud.org/ | S0, regional searches, Latin American literature, DeCS, and multilingual strategies. |
| Embase | Biomedical and pharmacological basis. | https://www.embase.com/ | S0, complementary biomedical search, pharmacology, devices, congresses, and Emtree terms when available. |
| Web of Science | Multidisciplinary base and citation analysis. | https://www.webofscience.com/ | S0, multidisciplinary search, citations, conference literature and identification of related works. |
| Scopus | Multidisciplinary database of abstracts, citations and scientific literature. | https://www.scopus.com/ | S0, multidisciplinary search, citations, conference proceedings, bibliometric analysis and export of results. |
| CINAHL / PsycINFO | Specialized bases in nursing, health sciences, psychology, behavior and mental health. | https://www.ebsco.com/products/research-databases/cinahl-database; https://www.apa.org/pubs/databases/psycinfo | S0, complementary searches when the question includes nursing, public health, psychology, behavior, or patient-centered outcomes. |
| ClinicalTrials.gov / WHO ICTRP | Registries of clinical trials and ongoing or unpublished studies. | https://clinicaltrials.gov/; https://trialsearch.who.int/ | S0, identification of registered studies, unpublished literature, ongoing trials, and publication bias. |
| Google Scholar / OpenAlex / Lens.org | Complementary search, citation tracking, grey literature, non-indexed documents and bibliometric exploration. | https://scholar.google.com/; https://openalex.org/; https://www.lens.org/ | Supplemental S0 and appointment verification; Document method, date, limits, and results reviewed. |
| Crossref | Verification of DOI, bibliographic metadata, titles, authors, and editorial data. | https://www.crossref.org/ | S0-S3, debugging references, DOI checking, and metadata enhancement before supplementation. |
| DeCS | Descriptors in Health Sciences for terminological standardization in Spanish, Portuguese and English. | https://decs.bvsalud.org/ | Preliminary phase and S0, translation of multilingual terms and strategies. |
| Resource | Main function | Web address | Use in S0-S3 |
| Zotero / EndNote / Mendeley | Bibliographic management, import/export, initial deduplication, organization of libraries and citation. | https://www.zotero.org/; https://endnote.com/; https://www.mendeley.com/ | S0-S1, reference library, RIS/BibTeX/CSV exports, initial deduplication and writing support. |
| Rayyan / Covidence | Collaborative screening, selection by title/abstract, full-text eligibility, conflict resolution and decision traceability. | https://www.rayyan.ai/; https://www.covidence.org/ | S1-S2, screening, eligibility, conflicts, decision export, and PRISMA count support. |
| EPPI-Reviewer / DistillerSR / ASReview | Platforms for screening, assisted prioritization, data extraction, forms, auditing, and automation according to tool and license. | https://eppi.ioe.ac.uk/cms/Default.aspx?tabid=2914; https://www.distillersr.com/; https://asreview.nl/ | S1-S3, prioritization, screening, eligibility, extraction, auditing, and machine learning-assisted review. |
| ZoteroBib | Quickly generate citations and bibliographies without creating a complete library. | https://zbib.org/ | Teaching support for one-off appointments; it does not replace Zotero, EndNote, or Mendeley in full reviews. |
| R Project | Statistical analysis and meta-analysis. | https://www.r-project.org/ | S3, statistical analysis and reproducible scripts. |
| R packages for meta-analysis | Metafor, meta, mada and diagmeta packages for meta-analysis, synthesis of effects and diagnostic accuracy. | https://www.metafor-project.org/; https://cran.r-project.org/package=meta; https://cran.r-project.org/package=mada; https://cran.r-project.org/package=diagmeta | S3, meta-analysis, sensitivity analysis and diagnostic synthesis. |
| JASP / Jamovi / MedCalc / Comprehensive Meta-Analysis | Statistical tools with useful modules or functions for analysis, meta-analysis, graphing and verification of results. | https://jasp-stats.org/; https://www.jamovi.org/; https://www.medcalc.org/; https://www.meta-analysis.com/ | S3, statistical analysis, meta-analysis, graphs, independent verification and teaching. |
| SRDR | Repository and tool for archiving and sharing data extracted from systematic reviews. | https://srdr.ahrq.gov/ | S3, repository of extraction matrices, transparency, reuse and updating of revisions. |
| OSF/Zenodo/Figshare | Deposit of materials, data and code. | https://osf.io/; https://zenodo.org/; https://figshare.com/ | Final repository, protocol, CSV matrices, code, supplementary material, versions, DOI and public traceability. |
References
- Pardal-Refoyo JL, Pardal-Peláez B. Anotaciones para estructurar una revisión sistemática. Rev ORL. 2020;11(2):155-60. [CrossRef]
- Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. [CrossRef]
- Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. [CrossRef]
- Rethlefsen ML, Kirtley S, Waffenschmidt S, Ayala AP, Moher D, Page MJ, et al. PRISMA-S: an extension to the PRISMA Statement for Reporting Literature Searches in Systematic Reviews. Syst Rev. 2021;10(1):39. [CrossRef]
- McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM, Clifford T, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: the PRISMA-DTA Statement. JAMA. 2018;319(4):388-96. [CrossRef]
- Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024. Available from: www.cochrane.org/handbook.
- Deeks JJ, Bossuyt PM, Leeflang MM, Takwoingi Y, editors. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy. Version 2.0. Cochrane; 2023. Available from: https://training.cochrane.org/handbook-diagnostic-test-accuracy.
- Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. [CrossRef]
- Sterne JAC, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. [CrossRef]
- Risk of Bias Tools. ROBINS-I V2 tool: risk of bias in non-randomized studies of interventions. Draft version. Bristol: University of Bristol; 2025. Available from: https://www.riskofbias.info/.
- Whiting PF, Rutjes AWS, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011;155(8):529-36. [CrossRef]
- Whiting PF, Tomlinson E, Rutjes AWS, Davenport CF, Yang B, Westwood ME, et al. QUADAS-3: a revised tool for the quality assessment of diagnostic test accuracy studies. Ann Intern Med. 2026;179(4):548-55. [CrossRef]
- Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2021. Available from: https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
- Schünemann H, Brożek J, Guyatt G, Oxman A, editors. GRADE Handbook for grading quality of evidence and strength of recommendations. Updated October 2013. GRADE Working Group; 2013. Available from: https://gdt.gradepro.org/app/handbook/handbook.html.
- Cochrane. RevMan: review-writing software. London: Cochrane; 2026. Available from: https://revman.cochrane.org/.
- GRADEpro GDT. GRADEpro guideline development tool: online integration with RevMan Web. Hamilton: Evidence Prime; 2026. Available from: https://www.gradepro.org/.
- Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1:2. [CrossRef]
- Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:l6890. [CrossRef]
- Flemyng E, Noel-Storr A, Macura B, Gartlehner G, Thomas J, Meerpohl JJ, et al. Position statement on artificial intelligence use in evidence synthesis across Cochrane, the Campbell Collaboration, JBI and the Collaboration for Environmental Evidence. Cochrane Database Syst Rev. 2025;2025:ED000178. [CrossRef]
- Holst D, Moenck K, Koch J, Schmedemann O, Schüppstuhl T. Transparent reporting of AI in systematic literature reviews: development of the PRISMA-trAIce checklist. JMIR AI. 2025;4:e80247. [CrossRef]
- Stern C, Jordan Z, McArthur A. Developing the review question and inclusion criteria. Am J Nurs. 2014;114(4):53-56. [CrossRef]
- Reitsma JB, Glas AS, Rutjes AWS, Scholten RJPM, Bossuyt PM, Zwinderman AH. Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. J Clin Epidemiol. 2005;58(10):982-90. [CrossRef]
- Rutter CM, Gatsonis CA. A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001;20(19):2865-84. [CrossRef]
- Brignardello-Petersen R, Santesso N, Guyatt GH. Systematic reviews of the literature: an introduction to current methods. Am J Epidemiol. 2025;194(2):536-542. [CrossRef]
- McKenzie JE, Brennan SE, Ryan RE, Thomson HJ, Johnston RV. Chapter 9: Summarizing study characteristics and preparing for synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al., editors. Cochrane Handbook for Systematic Reviews of Interventions. Version 6.5. Cochrane; 2024. Available from: https://www.cochrane.org/authors/handbooks-and-manuals/handbook/current/chapter-09.
- von Pressentin KB, Shabani JS, Young T. Integrating evidence synthesis into doctoral research: a guide for family medicine and primary care. Afr J Prim Health Care Fam Med. 2025;17(2):a5198. [CrossRef]
- Whaley P, Garside R, Eales JF. A General Protocol for Pilot-Testing the Screening Stage of a Systematic Review. protocols.io. 2020. [CrossRef]
- Ruangsomboon O, Lima JP, Eltorki M, Worster A. Methodological standards in the design and reporting of pilot and feasibility studies in emergency medicine literature: a systematic review. BMJ Open. 2024;14(11):e082648. [CrossRef]
- Ringsten M, Styrmisdottir L, Naesström M, Johansson M, Bruschettini M, Wallerstedt SM. Systematic Reviews as Part of Doctoral Theses and for the Promotion to Associate Professor: A Descriptive Study of University Policies in Sweden. Cochrane Evid Synth Methods. 2026;4(1):e70069. [CrossRef]
- PRISMA Statement. PRISMA 2020 statement. Oxford: PRISMA; 2026. Available from: https://www.prisma-statement.org/prisma-2020-statement.
- BIREME/PAHO/WHO. DeCS – Health Sciences Descriptors. São Paulo: Virtual Health Library; 2026. Available from: https://decs.bvsalud.org/.
- Pan American Health Organization. DeCS 2025 edition is available. Washington, DC: PAHO/WHO; 2025. Available from: https://www.paho.org/es/noticias/30-4-2025-decs-edicion-2025-esta-disponible.
- Bramer WM, de Jonge GB, Rethlefsen ML, Mast F, Kleijnen J. A systematic approach to searching: an efficient and complete method to develop literature searches. J Med Libr Assoc. 2018;106(4):531-541. [CrossRef]
- McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS Peer Review of Electronic Search Strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40-46. [CrossRef]
- Atkinson LZ, Cipriani A. How to carry out a literature search for a systematic review: a practical guide. BJPsych Adv. 2018;24(2):74-82. [CrossRef]
- Calderon Martinez E, Flores Valdés JR, Castillo JL, Castillo JV, Blanco Montecino RM, Morin Jimenez JE, et al. Ten steps to conduct a systematic review. Cureus. 2023;15(12):e51422. [CrossRef]
- Covidence. A practical guide: protocol development for systematic reviews. Melbourne: Veritas Health Innovation; 2024. Available from: https://www.covidence.org/.
- Pardal Refoyo JL, Soto Varela A, López Poveda E, Caballero Borrego M. Estrategias y herramientas de inteligencia artificial para mejorar la investigación bibliográfica en Otorrinolaringología. Libro Blanco SEORL-CCC 2025. Madrid: Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello; 2025.
- Pardal Refoyo JL, Soto Varela A, López Poveda EA, Caballero Borrego M. Metodología para realizar una revisión bibliográfica. En: Actualización SEORL 2026. Capítulo 110. Madrid: Sociedad Española de Otorrinolaringología y Cirugía de Cabeza y Cuello; 2026. En prensa. Disponible en: https://www.actualizacion.seorl.net/article?id=6a27d7e8-da6c-4be1-a076-74100aca0133&columns=1.







| Area | Change from the previous approach | Practical justification |
| PRISMA | Replace PRISMA 2009 with PRISMA 2020 and its relevant extensions [2,3]. | PRISMA 2020 includes a list of 27 items, updated diagram, automation report, data availability and certainty of evidence. |
| Protocol | Make the protocol and prospective registration explicit. | Registration, access to the protocol, amendments, and justification must be indicated if not registered. |
| Search | Document complete strategies by source. | PRISMA-S requires bases, platforms, dates, limits, filters, deduplication, and peer review of searches where appropriate [4]. |
| Risk of bias | Abandon the generic idea of “quality” as a total score. | Use tools by design: RoB 2, ROBINS-I, QUADAS-2/3, Newcastle-Ottawa when warranted [8,9,10,11,12,13]. |
| Certainty | Distinguish risk of bias from global certainty. | GRADE assesses confidence in the body of evidence by outcome, not the isolated quality of each article [14]. |
| Software | Upgrade RevMan 5 to RevMan Web and companion tools. | RevMan Web, GRADEpro GDT, Rayyan, Covidence, EPPI-Reviewer, Zotero/EndNote/Mendeley, and open repositories [15,16]. |
| AI | Add transparency and human oversight. | Any automation that suggests decisions must be justified, validated, monitored, and reported [19,20]. |
| Practical Strategy for Writing the IMRD Final Report | ||
|
1. Starting point A clear, well-argued question derived from a preliminary bibliographic exploration. From it come the title, the keywords, the criteria, the search, the analysis and the interpretation. |
2. Drafting order Objectives → methods → analysis/results → interpretation/discussion → conclusions → introduction → abstract in Spanish and English. The manuscript reads like IMRD, but is written from the most verifiable elements. |
3. Differentiated bibliography The introduction uses contextual and preliminary bibliography. The methods cite guides and tools. Results and discussion are supported by the included studies and the evidence needed to interpret the findings. |
| S0-S3 maintains traceability: S0 formulates and justifies the question; S1-S2 document the selection; S3 defines the core evidence of results and discussion. | ||
|
Principle The review question functions as the methodological blueprint for the entire review. If the question changes after examining the results, the change must be recorded as an amendment and justified. |
| Literature research for a systematic review: two connected phases | ||||
|
Preliminary phase Design the research before the definitive systematic search: delimit the problem, review exploratory literature, identify gaps, formulate initial question, conduct pilot search, adjust objectives, criteria, terms, and strategy, and write the registrable protocol [17,21,37]. |
→ Stabilized question and protocol |
Development phase Execute the review already designed using S0-S3: identify records, screen titles and abstracts, evaluate full texts, include studies, extract data, assess risk of bias, synthesize evidence, and prepare the report [2,3,4,6]. |
||
|
1. Define problems, concepts and gaps |
2. Pilot terms, sources and criteria |
3. Record protocol and plan |
4. Run S0-S3 Identify, Screen, Choose, and Include |
5. Report PRISMA, synthesis and IMRD |
| Rule of thumb: The preliminary phase allows the question to be adjusted and subsequent changes to be reduced; the development phase executes the protocol and documents any substantial changes as an amendment [2,17,30]. | ||||
| Schematic S0-S3 | Correspondence with PRISMA 2020 | Documented decision |
|
S0 Identification All records |
Records identified in databases, records, gray literature, or other sources [2,4]. | Total number retrieved by source and records deleted prior to screening, including duplicates. |
|
▼ S1 Screening Title, abstract and keywords |
Screened records and excluded records after reading the title and abstract, with reviewers, independence and automation documented where appropriate [2,3]. | Preliminary decision: high priority, medium priority, low priority, or exclude. |
|
▼ S2 Eligibility Full text and extractable data |
Reports sought for recovery, reports evaluated for eligibility, and reports excluded for explicit reason [2,3]. | Full-text decision: include, perhaps, or exclude, with primary reason for exclusion. |
|
▼ S3 Final inclusion Qualitative synthesis and/or meta-analysis |
Studies included in the review and, if applicable, studies included in each meta-analysis, narrative synthesis, or outcome synthesis [6,18,25]. | Final inclusion for narrative synthesis, quantitative synthesis, outcome analysis, and evidence tables. |
| Stage | Contributes to the PRISMA diagram | Contribute to IMRD manuscript |
| S0 Identification | Records identified by source and records deleted prior to screening, including duplicates [2,4,33]. | Introduction: justification and question. Methods: protocol, sources, search strategies, limits, and record management. |
| S1 Screening | Screened records and excluded records by title, abstract and keywords, with a transparent and reproducible selection process [2,3]. | Methods: screening process, reviewers, discrepancies and automation. Results: number of excluded records. |
| S2 Eligibility | Reports searched, not retrieved, evaluated in full text and excluded with explicit reason [2,3]. | Methods: Eligibility criteria applied to full text. Results: exclusions with reason and table/annex of excluded texts. |
| S3 Final Inclusion | Studies included in the review, in the narrative synthesis and, if appropriate, in each meta-analysis or synthesis by outcome [6,18,25]. | Results: characteristics, risk of bias, synthesis, and GRADE. Discussion and conclusions: interpretation, limitations and implications. |
| CSV S0 Block | Recommended fields |
| Identifier | id_s0; source; search number; Date |
| Reference | authors; year; title; journal; volume; pages; DOI/PMID/URL |
| Summary | abstract; keywords; language; Document type |
| Search | search equation; platform; filters; limits; number of results |
| Traceability | original exported file; RIS/BibTeX/CSV export format; download date; responsible; prompt_IA_S0 if applicable; salida_IA_S0 if applicable |
|
Responsible use of AI in S1 AI can suggest or prioritize decisions, but it cannot replace the reviewer. If you classify records, inputs, outputs, version, date, prompts or parameters, internal validation, and human review must be preserved. The prompt should be archived with the search strategies and include parsed fields, inclusion/exclusion rules, priority categories, output format, and justification for each recommendation with verifiable metadata. |
| Exclusion category in S2 | Operational definition |
| Population | Does not match PICO/PIRD; age, disease, context, or ineligible subgroup. |
| Intervention/Test/Exposure | The intervention, index test or exposure does not correspond to the review question. |
| Comparator or reference | Inadmissible comparator or inadequate reference standard. |
| Outcomes | Does not report the predefined outcomes or does not allow construction of effect or accuracy measures. |
| Design | Type of study excluded by protocol. |
| Data | Insufficient, non-extractable data or non-resolvable overlap. |
| Design | Recommended tool | Methodological use |
| Randomized trials | RoB 2 | Evaluates specific results from randomized trials; Includes versions for cluster and crossover assays. |
| Non-randomised studies of interventions | ROBINS-I / ROBINS-I V2 | Domain-by-domain approach against a hypothetical target trial; attention to confounding, selection, classification and missing data. |
| Diagnostic accuracy | QUADAS-2; QUADAS-3 | QUADAS-2 retains extended use; QUADAS-3 appears as a revised tool focused on estimates of accuracy and applicability. |
| Observational cohorts/case-controls | Newcastle-Ottawa Scale | Star-based tool for selection, comparability and exposure/outcome assessment; useful when its adaptation and limitations are declared. |
| Previous systematic reviews | AMSTAR 2 / ROBIS | To rate reviews included in umbrella reviews or overviews. |
| Predictive models | PROBAST / TRIPOD | When the question evaluates prognostic models or predictive diagnoses. |
| Guide/Extension | When to use it |
| PRISMA 2020 | General report of systematic reviews and meta-analyses. |
| PRISMA-S | Detailed report of bibliographic searches. |
| PRISMA-DTA | Diagnostic accuracy reviews. |
| PRISMA-P | Systematic review protocols. |
| PRISMA-ScR | Scoping reviews. |
| PRISMA-NMA | Network meta-analysis. |
| PRISMA-Harms | Harms or adverse events. |
| SWiM | Synthesis without meta-analysis of effect estimates. |
| Folder | Recommended content |
| /00_protocol | Protocol, registration, amendments and PRISMA-P checklist. |
| /01_searches_S0 | Complete strategies by search engine, dates, filters, limits, number of results obtained in S0, captures, original RIS/BibTeX/CSV exports, searches stored in Zotero or another manager, CSV S0 and complementary documentation file. |
| /02_screening_S1 | Deduplication, title/abstract decisions, conflicts, CSV S1, and, if applicable, RIS/BibTeX of included, excluded, or questionable records. |
| /03_full_texts_S2 | PDFs, table of exclusions, reasons, CSV S2, and, if applicable, RIS/BibTeX of included, excluded, or questionable reports. |
| /04_extraction_S3 | Forms, variable dictionary, extraction, risk of bias, CSV S3, Excel file with result sheets and data matrices, and RIS/BibTeX references of studies included or excluded by synthesis. |
| /05_analysis | R/Stata/RevMan Web scripts, forest plots, SROC curves and sensitivity analyses. |
| /06_grade | SoF tables, evidence profiles, GRADE justifications. |
| /07_manuscript | Word document of the research report, main text, tables, figures, annexes, final checklist and versions sent to the journal or repository. |
| /08_repository | Shareable data, code, data matrices, supplementary materials, reproducible supplementary document, DOI if applicable. |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).